axicabtagene ciloleucel,lisocabtagene maraleucel
bms,daiichi sankyo,gilead
['axicabtagene ciloleucel', 'axi-cel', 'liso-cel', 'lisocabtagene maraleucel', 'lymphoma', 'lisocabtagene']
#ash22 | hall d | sat 5:30pm cst
matching-adjusted indirect comparison (maic) of lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel) for second-line (2l) treatment of patients (pt) with refractory/early relapsed (r/r) large b-cell lymphoma (lbcl) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.